Trial Profile
A study assessing triple therapy with prasugrel or ticagrelor compared to clopidogrel after percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2016
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Aspirin; Clopidogrel; Warfarin
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 09 Oct 2016 New trial record